Cytodyn Inc (CYDY): CytoDyn (CYDY) Given a $2.00 Price Targe...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

Cytodyn Inc (CYDY)

Reply Private New

Next 10 Prev Next

Send PM

Followers	28
Posts	1014
Boards Moderated	0
Alias Born	03/10/2014

FREE
CYDY REPORT

Re: None

Wednesday, 02/14/2018 1:21:58 AM

Wednesday, February 14, 2018 1:21:58 AM

CytoDyn (CYDY) Given a $2.00 Price Target at HC Wainwright

Xavier Javi
CytoDyn logoCytoDyn (OTCMKTS:CYDY) received a $2.00 target price from HC Wainwright in a report issued on Tuesday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price target would indicate a potential upside of 220.00% from the company’s current price.

Shares of CytoDyn (CYDY) opened at $0.63 on Tuesday. CytoDyn has a 12 month low of $0.46 and a 12 month high of $0.84. The company has a market capitalization of $108.67, a price-to-earnings ratio of -2.72 and a beta of 0.83.

About CytoDyn
CytoDyn Inc is a clinical-stage biotechnology company. The Company is focused on the clinical development and commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The Company’s lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells.

In My Own Personal Opinion Of Course!

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent CYDY News

Current Report Filing (8-k) • Edgar (US Regulatory) • 03/08/2023 10:16:28 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 10:16:29 PM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:12:51 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:12:34 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:11:19 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:10:56 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:10:55 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:09:37 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:09:32 AM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:09:29 AM
Post-effective Amendment to Registration Statement (pos Am) • Edgar (US Regulatory) • 02/03/2023 10:23:17 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/01/2023 10:16:24 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 01/09/2023 10:30:29 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/19/2022 10:20:44 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 12/07/2022 04:04:32 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/07/2022 04:02:07 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/07/2022 11:02:17 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 12/07/2022 11:01:33 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/25/2022 10:16:33 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/17/2022 11:54:40 PM

More CYDY News

InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!